A detailed history of Capital Investment Counsel, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Investment Counsel, LLC holds 2,912 shares of LLY stock, worth $2.42 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
2,912
Previous 2,927 0.51%
Holding current value
$2.42 Million
Previous $2.28 Billion 15.78%
% of portfolio
0.52%
Previous 0.49%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $10,873 - $13,635
-15 Reduced 0.51%
2,912 $2.64 Billion
Q1 2024

Aug 14, 2024

BUY
$592.2 - $792.28 $1.73 Million - $2.32 Million
2,927 New
2,927 $2.28 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $790B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capital Investment Counsel, LLC Portfolio

Follow Capital Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Counsel, LLC with notifications on news.